Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.
Launched by HOSPITAL CENTRAL "DR. IGNACIO MORONES PRIETO" · Aug 13, 2019
Trial Information
Current as of July 08, 2025
Completed
Keywords
ClinConnect Summary
A pilot study will be conducted in patients older than 18 years with a diagnosis of rheumatoid arthritis in the Hospital Central "Dr. Ignacio Morones Prieto", these patients will be evaluated by the rheumatologist and the patients with and patients with severe activity according of the Disease Activity Score 28 (DAS 28\> 5.1) will be invited to their recruitment, a history of ischemic heart disease, heart failure or chronic kidney disease will be reviewed for its exclusion. This is a randomized controlled clinical trial blinded to the rheumatologist and the cardiologist who will carry out t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients older than 18 years with a diagnosis of rheumatoid arthritis according to the diagnoses of the American College of Rheumatology and the European League against rheumatism 2010 with severe disease activity according to DAS 28\> 5.1.
- • Patients who are accepted according to previous criteria and with signed informed consent.
- Exclusion Criteria:
- • Patients with a history of ischemic heart disease.
- • Patients with a history of heart failure with decreased left ventricular ejection fraction
- • Patients with chronic kidney disease.
About Hospital Central "Dr. Ignacio Morones Prieto"
Hospital Central "Dr. Ignacio Morones Prieto" is a leading medical institution dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence in patient care, the hospital serves as a pivotal center for conducting clinical trials that aim to evaluate new treatments and improve therapeutic outcomes. Equipped with state-of-the-art facilities and a team of experienced healthcare professionals, the hospital fosters an environment of collaboration and scientific inquiry, ensuring rigorous adherence to ethical standards and regulatory compliance. By participating in cutting-edge research, Hospital Central "Dr. Ignacio Morones Prieto" contributes significantly to the advancement of medical knowledge and the enhancement of patient health within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Luis Potosí, , Mexico
Patients applied
Trial Officials
Juan M Lopez, MD
Study Chair
Ethics committee of the Hospital Central "Dr Ignacio Morones Prieto"
Emmanuel Rivera, MD
Study Chair
Research committee of the Hospital Central "Dr Ignacio Morones Prieto"
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials